VP and CFO of HiTech Pharmacal Co. Inc. (HITK) William J Peters sells 2,517 shares of HITK on 01/05/2010 at an average price of $29.02 a share.

Hitech Pharmacal Co. Inc. has a market cap of $337.1 million; its shares were traded at around $28.49 with a P/E ratio of 15.8 and P/S ratio of 3.1.

HITK is in the portfolios of Chuck Royce of ROYCE & ASSOCIATES, Arnold Van Den Berg of Century Management, Bruce Kovner of Caxton Associates.

This is the annual revenues and earnings per share of HITK over the last 10 years. For detailed 10-year financial data and charts, go to 10-Year Financials of HITK.

CEO Recent Trades:

• Sell:: CEO, President, Sec'y, Treas., 10% Owner David S Seltzer sold 30,000 shares of HITK stock on 10/07/2009 at the average price of 23.45, the price of the stock has increased by 21.49% since.


• Sell:: CEO, President, Sec'y, Treas., 10% Owner David S Seltzer sold 40,000 shares of HITK stock on 09/29/2009 at the average price of 21.49, the price of the stock has increased by 32.57% since.


• Sell:: CEO, President, Sec'y, Treas., 10% Owner David S Seltzer sold 153,776 shares of HITK stock on 09/15/2009 at the average price of 21.05, the price of the stock has increased by 35.34% since.


• Sell:: CEO, President, Sec'y, Treas., 10% Owner David S Seltzer sold 16,224 shares of HITK stock on 07/16/2009 at the average price of 12.66, the price of the stock has increased by 125.04% since.

CFO Recent Trades:

• Sell:: VP and CFO William J Peters sold 6,250 shares of HITK stock on 12/11/2009 at the average price of 22.62, the price of the stock has increased by 25.95% since.


• Sell:: VP and CFO William J Peters sold 26,250 shares of HITK stock on 10/14/2009 at the average price of 25.05, the price of the stock has increased by 13.73% since.


• Sell:: VP and CFO William J Peters sold 10,800 shares of HITK stock on 09/30/2009 at the average price of 22.81, the price of the stock has increased by 24.9% since.


• Sell:: VP and CFO William J Peters sold 56,250 shares of HITK stock on 09/11/2009 at the average price of 21.86, the price of the stock has increased by 30.33% since.

This is the insider trade history vs. stock price of HITK. For the complete insider trading history of HITK, click here.

Directors and Officers Recent Trades:

• Sell:: Director Hulst Jack Van sold 3,094 shares of HITK stock on 12/29/2009 at the average price of 28.34, the price of the stock has increased by 0.53% since.


• Sell:: Director Bruce W Simpson sold 15,469 shares of HITK stock on 12/11/2009 at the average price of 23.29, the price of the stock has increased by 22.33% since.


• Sell:: President, HCP Division Gary M April sold 58,125 shares of HITK stock on 12/11/2009 at the average price of 23.07, the price of the stock has increased by 23.49% since.


• Sell:: Director Yashar Hirshaut sold 11,250 shares of HITK stock on 10/16/2009 at the average price of 24.5, the price of the stock has increased by 16.29% since.


• Sell:: Director Reuben Seltzer sold 35,916 shares of HITK stock on 10/15/2009 at the average price of 24.92, the price of the stock has increased by 14.33% since.

Why CEOs Are Buying Stocks Of Their Own Companies?

1. As legendary investor Peter Lynch said: "Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise."
2. TOP EXECUTIVES like CEOs and CFOs are savvy buyers of their companies' shares. One long-term study showed that they beat the market on average by six percentage points a year.
3. Another study found that the aggregated activities of insiders can serve as a good indicator to locate market bottoms. Insiders as a whole are smart investors of their own companies.

Click it to Check Out What the CEO Are Trading

More Gurufocus Links

Latest Guru Picks	Value Strategies
Warren Buffett Portfolio	Ben Graham Net-Net
Real Time Picks	Buffett-Munger Screener
Aggregated Portfolio	Undervalued Predictable
ETFs, Options	Low P/S Companies
Insider Trends	10-Year Financials
52-Week Lows	Interactive Charts
Model Portfolios	DCF Calculator
RSS Feed	Monthly Newsletters
The All-In-One Screener	Portfolio Tracking Tool